Starting today Dr. Ian Wilkinson joins mAbsolve as Chief Scientific Officer, having been a Founder and non-executive Director since the company’s induction in December 2020. Ian brings a wealth of experience in the development and commercialisation of antibody technologies having previously been Chief Scientific Officer at Absolute Antibody, taking that organisation from start-up through to a successful acquisition.
